News2 mins ago
Kelyniam Global Releases Q1 Financials, Announces Licensing Agreement with Bioplate for Osteopore Products
CANTON, Conn., May 22, 2023 /PRNewswire/ — Kelyniam Global (OTC: KLYG), a leading maker of custom cranial implants, today announced results for its quarter ended March 31, 2023. “I’m pleased to announce that Kelyniam has...
